Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.
Rocket Lab signed a new multi-launch deal with Japanese Earth imaging company iQPS for three dedicated Electron missions.
The agreement expands an existing launch partnership and lifts the total planned missions between the companies to 18.
This latest contract focuses on deploying iQPS satellites for its synthetic aperture radar constellation.
Rocket Lab, listed as NasdaqGS:RKLB, continues to build out its commercial launch backlog at a time when its stock has been volatile. The share price is $64.68, with the stock up 40.9% over the past year, down 36.4% over the past month, and down 14.9% year to date. The new agreement with iQPS adds another set of contracted flights to its Electron manifest and extends Rocket Lab’s role as a launch provider for commercial Earth imaging customers.
For investors watching NasdaqGS:RKLB, this deal points to additional contracted revenue from non government customers and a deeper relationship with a repeat satellite operator. The three-launch commitment, on top of prior bookings, may help support a more predictable launch cadence and cash flow planning over time, although the actual financial impact will depend on pricing, margins, and execution on these 18 planned missions.
Stay updated on the most important news stories for Rocket Lab by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Rocket Lab.
NasdaqGS:RKLB Earnings & Revenue Growth as at Jul 2026
Investor Checklist: Rocket Lab and the iQPS Deal Quick Assessment
✅ Price vs Analyst Target: Rocket Lab trades at US$64.68 versus a consensus analyst target of US$114.47, which is about 44% higher than the current price.
✅ Simply Wall St Valuation: The stock is flagged as trading 23.1% below an estimated fair value, which supports the undervalued status.
❌ Recent Momentum: The share price has fallen 36.4% over the last 30 days, showing weak short term sentiment.
There’s only one way to know the right time to buy, sell or hold Rocket Lab. Head to Simply Wall St’s company report for the latest analysis of Rocket Lab’s Fair Value.
Key Considerations
📊 The new iQPS multi launch deal adds contracted missions that may support Rocket Lab’s commercial revenue base if missions execute as planned.
📊 Watch how the launch cadence, Electron mission margins, and any updates to revenue guidance line up with this expanded 18 mission partnership.
⚠️ The stock has a highly volatile share price and recent declines, so price swings around execution or schedule changes on these launches are a key risk.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Rocket Lab analysis. Alternatively, you can check out the community page for Rocket Lab to see how other investors believe this latest news will impact the company’s narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include RKLB.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com